Biogen Message Board - Msg: 10090199

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 156.28

+0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JEB who wrote (1018)	6/11/1999 10:30:00 PM
From: P.M.Freedman	Read Replies (2) of 1686

BGEN has more than tripled its values in one year. What's the driving force? Of course, it's the highly speculated Avonex. That's why everybody liked it. The prices of BGEN fully rely on Avonex. If sales of Avonex slow down, BGEN will follow. I believe that the growth based soly on Avonex, a drug with low patient population, has been being close to its end. I might be wrong :-) To me, if an already highly priced stock was still fully recommended by those analysts, I would take axtra attention and caution on it. Mostly I would unload my positions so as to go to a stock that those analysts rated as a hold. Good luck!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next